Organic compounds -- part of the class 532-570 series – Organic compounds – Nitriles
Reexamination Certificate
2011-01-04
2011-01-04
Keys, Rosalynd (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitriles
C558S388000
Reexamination Certificate
active
07863475
ABSTRACT:
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
REFERENCES:
patent: 4011321 (1977-03-01), Coates et al.
patent: 4098816 (1978-07-01), Thorne et al.
patent: 4474809 (1984-10-01), Floyd, Jr. et al.
patent: 4638094 (1987-01-01), Nakai et al.
patent: 4845231 (1989-07-01), Kees
patent: 4895862 (1990-01-01), Alessi et al.
patent: 5665387 (1997-09-01), Mathieu et al.
patent: 5817693 (1998-10-01), Cousins et al.
patent: 5948803 (1999-09-01), Maeda et al.
patent: 6045773 (2000-04-01), Isakson et al.
patent: 6180627 (2001-01-01), Blagg et al.
patent: 6376512 (2002-04-01), Jayyosi et al.
patent: 6403636 (2002-06-01), Reutrakul et al.
patent: 6555536 (2003-04-01), Burris et al.
patent: 6858602 (2005-02-01), Sharma et al.
patent: 6916848 (2005-07-01), Sharma
patent: 6924314 (2005-08-01), Sharma et al.
patent: 6946491 (2005-09-01), Sharma et al.
patent: 7012071 (2006-03-01), Sharma et al.
patent: 7041659 (2006-05-01), Sharma
patent: 7045541 (2006-05-01), Sharma
patent: 7101910 (2006-09-01), Sharma et al.
patent: 2002/0028943 (2002-03-01), Griffin
patent: 2003/0191323 (2003-10-01), Ikawa et al.
patent: 2004/0214901 (2004-10-01), Antel et al.
patent: 2005/0090555 (2005-04-01), Sharma et al.
patent: 2005/0256333 (2005-11-01), Sharma et al.
patent: 2006/0014784 (2006-01-01), Hodge et al.
patent: 2006/0035970 (2006-02-01), Hodge et al.
patent: 2006/0247309 (2006-11-01), Hodge et al.
patent: 2007/0105955 (2007-05-01), Hodge et al.
patent: 2007/0105958 (2007-05-01), Sharma et al.
patent: 2007/0173544 (2007-07-01), Hodge et al.
patent: 2007/0249696 (2007-10-01), Sharma et al.
patent: 2007/0249719 (2007-10-01), Sharma et al.
patent: 9802163 (2000-11-01), None
patent: 1929165 (1969-12-01), None
patent: 2309986 (1974-08-01), None
patent: 2459468 (1975-07-01), None
patent: 2512673 (1975-10-01), None
patent: 2527066 (1976-01-01), None
patent: 3012012 (1981-10-01), None
patent: 071399 (1983-02-01), None
patent: 0288190 (1988-10-01), None
patent: 0393400 (1990-10-01), None
patent: 0407891 (1991-01-01), None
patent: 330613 (1993-08-01), None
patent: 629624 (1994-12-01), None
patent: 5.035 (1967-05-01), None
patent: 2191887 (1974-02-01), None
patent: 1488330 (1977-10-01), None
patent: 47025149 (1972-10-01), None
patent: 50014653 (1975-02-01), None
patent: 52025734 (1977-02-01), None
patent: 55015460 (1980-02-01), None
patent: 56115747 (1981-09-01), None
patent: 61040270 (1986-02-01), None
patent: 01063570 (1989-03-01), None
patent: 04159266 (1992-06-01), None
patent: 10130241 (1998-05-01), None
patent: 01/181281 (2001-07-01), None
patent: 88/08418 (1988-11-01), None
patent: 92/12123 (1992-07-01), None
patent: 93/08799 (1993-05-01), None
patent: 94/27993 (1994-12-01), None
patent: 95/13262 (1995-05-01), None
patent: 97/30017 (1997-08-01), None
patent: 98/03505 (1998-01-01), None
patent: 99/62520 (1998-01-01), None
patent: 98/07681 (1998-02-01), None
patent: 98/08836 (1998-03-01), None
patent: 98/25608 (1998-06-01), None
patent: 99/11255 (1999-03-01), None
patent: 99/19291 (1999-04-01), None
patent: 99/20275 (1999-04-01), None
patent: 99/62520 (1999-12-01), None
patent: 00/23409 (2000-04-01), None
patent: 00/63161 (2000-10-01), None
patent: 01/40170 (2001-06-01), None
patent: 01/81340 (2001-11-01), None
patent: 02/02119 (2002-01-01), None
patent: 02/14291 (2002-02-01), None
patent: 02/59077 (2002-08-01), None
patent: 05/019151 (2005-03-01), None
patent: 6705655 (1968-02-01), None
Miyano et al., Nippon Nogei Kagaku Kaishi, 1960, 34(8), abstract.
Gerhauser et al., Nature Medicine, Mar. 1995, vol. 1, No. 3, pp. 260-266.
Bruce Davis, Journal of Labelled Compounds and Radiopharmaceuticals, vol. XXIV, No. 2, Mar. 1986, pp. 199-204.
Pending (as of Sep. 20, 2007) claims from U.S. Appl. No. 10/566,302.
Chemical Abstract DN:128:154084, corresponding to Momose, et al. WO98/03505 (1998), See compound RN152380-68-2.
Chemical Abstract DN: 130: 237567, corresponding to Tajima, et al. WO99/11255 (1999), See compounds RN 221258-65-7, 221258-68-0 and 221261-93-4.
Chemical Abstract DN: 130:281874, corresponding to Shoda, et al. WO99/19291 (1999). See compounds RN 222627-31-8 and 222627-32-9.
Chemical Abstract DN: 65:20620, corresponding to Carlo, BE 667498 (1965). See compounds RN 6686-26-6.
Chemical Abstract DN: 111:232835, also cited as US Patent No. 4,845,231,1989.
Chemical Abstract DN: 123: 143900, also cited as EP 629624,1994.
Chemical Abstract DN: 112: 120706, also cited as EP 3330613,1989.
Chemical Abstract DN: 56:31154, also cited as Jerumanis, et al., “Spectrographic Methods for the detection . . . ”, Bulletin des Societes Chimiques Belges, 69, 312-22, 1960.
Chemical Abstract DN: 126:343566, also cited as 6045773, 2000.
Witiak, et al., “Synthesis of Ethyl 6-Substituted-Chromone-2-carboxylates. A Comparative Structure-Activity Study Employing the 6-Phenyl and Phenoxy Analogs in the Triton Hyperlipidemic Rat Model”, Journal Medical Chemistry, vol. 18, No. 9, pp. 934-942, 1975.
Karche, et al., “Electronic Effects in Migratory Groups . . . ” Journal of Organic Chemistry, vol. 66, No. 19, pp. 6323-6332, 2001. (Abstract).
Poupardin, et al., “First approach to the cycloisodityrosine unit of RA-IV”, Tetrahedron Letters, vol. 42, No. 8, pp. 1523-1526, 2001. (Abstract).
Manthey, et al., “Synthesis of Human Ultraviolet Filter Compounds . . . . ” Journal of Organic Chemistry, vol. 64, No. 11, pp. 3930-3933, 1999. (Abstract).
Wu, et al., “Improvement on the preparation of beta-keto esters”, Huaxue Shiji, vol. 20, No. 6, pp. 376-377, 1998. (Abstract).
Wu, et al., “Total syntheses of furoguaiacin and related analogs”, Huaxue Yanjiu Yu Yingyoung, vol. 9, No. 6, pp. 595-599, 1997. (Abstract).
Fadnavis, et al., “Baker's yeast mediated enantiospecific of anti-(2R,3R) . . . ”, Tetrahedron Asymmetry, vol. 8, No. 24, pp. 4003-4006, 1997. (Abstract).
Wu, et al., “A modification of the Knorr oxidative coupling method for preparation of 1,4-diketones”, Synthetic Communications, vol. 27, No. 2, pp. 331-336, 1997. (Abstract).
Girard, et al., “Syntheses of the syn and anti .alpha .-amino-.beta.-hydroxy acid of vancomycin . . . ” Tetrahedron Letters, vol. 37, No. 44, pp. 7967-7970. 1996. (Abstract).
Smith, et al. “Synthesis and PAF antagonist activity of some 2,5-diaryltetrahydrofurans incorporation PAF-like functional groups”, European Journal of Medicinal Chemistry, vol. 31, No. 5, pp. 347-358, 1996. (Abstract).
Maruyama, et al., “A synthesis of (.+−.)-pinoresinol and its related compound using potassium persulfate (K2S208) oxidation of benzoylacetates”, Heterocycles, vol. 37, No. 2, pp. 839-845, 1994, (Abstract).
Rao, et al., “Studies on cyclodepsipeptides. Part II. The total synthesis of jaspamide and geodiamolide-D”, Tetrahedron Letters, vol. 34, No. 44, pp. 7085-7088, 1993 (Abstract).
Colotta, et al., “Tricyclic heteroaromatic systems . . . ”, Farmaco, vol. 46, No. 10, pp. 1139-1154, 1991. (Abstract).
Dillard, et al., “(Phenylmethoxy) phenyl derivatives of w-oxo and w-tetrazolylalkanoic acids . . .” J. Med. Chem., vol. 34, No. 9, pp. 2768-2778, 1991. (Abstract).
Bose, et al., “Synthesis of 4-phenylcoumarins from Dalbergia volubilis and Exostema caribaeum”, Phytochemistry, vol. 30, No. 7, pp. 2438-2439. 1991. (Abstract).
Bose, et al., “Synthesis of 4-phenylcoumarins”, Indian J. Chem., Sect. B, vol. 29B, No. 5, pp. 422-444, 1990. (Abstract).
Colotta, et al., “Tricyclic heteroaromatic systems . . . ”, J. Med. Chem., vol. 33, No. 9, pp. 2646-2651, 1990. (Abstract).
Kameo, et al., “Studies on hypolipidemic agents, IV. 3-[4-(Phenylthio) benzoyl] propionic acid derivatives”, Chem. Pharm. Bull., vol. 37, No. 5, pp. 1260-1267, 1989, (Abstract).
Colotta, et al., “Tricyclic heteroaromatic systems: synthes
Keys Rosalynd
Kreisler Lewis J.
Wellstat Therapeutics Corporation
LandOfFree
Compounds for the treatment of metabolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for the treatment of metabolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of metabolic disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2650020